Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Posted on by ScienceFather

Prof. Chyi-Liang Chen | Molecular epidemiology | Best Researcher Award

Prof. Chyi-Liang Chen, Linkou Chang Gung Memorial Hospital Children’s Medical Center, Taiwan

🧬 Prof. Chyi-Liang Chen is an Associate Researcher at Chang Gung Memorial Hospital and the Department of Microbiology and Immunology, Chang Gung University, Taiwan. He earned his BSc, MSc, and PhD in Life Sciences from National Chung Hsing University. With extensive postdoctoral research at Chang Gung University and the University of Calgary, his expertise spans microbiology, molecular microbiology, protein engineering, bacterial genomics, and antimicrobial resistance. He has authored numerous SCIE-indexed publications on bacterial pathogenesis and genetic engineering. His work contributes to biotechnology, genomics, and patent applications, advancing microbial research. πŸ¦ πŸ”¬πŸ“š

Publication Profile

Scopus

Orcid

πŸŽ“ Educational Background

Prof. Chyi-Liang Chen pursued his academic journey in Life Sciences at National Chung Hsing University, Taiwan. He obtained his Bachelor’s degree (1984–1988) from the Department of Life Sciences (formerly the Department of Botany). He then completed his Master’s degree (1988–1990) at the Institute of Life Sciences (previously the Institute of Botany Microbiome). Further advancing his expertise, he earned a Ph.D. (1990–1995) from the same institute. His strong foundation in microbiology, molecular biology, and botany has significantly contributed to his impactful research in bacterial genomics and biotechnology. πŸ§¬πŸ”¬πŸ“–

πŸ… Professional Experience

Prof. Chyi-Liang Chen has an extensive career in microbiology and immunology. He began as a Postdoctoral Fellow at Chang Gung University, Taiwan (1997–1999) before moving to the University of Calgary, Canada (1999–2002). He later returned to Chang Gung University (2002–2006). He served as an Assistant Professor at Yuanzhi University and later as an Assistant Researcher at Chang Gung Memorial Hospital (2006–2012). Since 2012, he has been an Associate Researcher at Chang Gung Memorial Hospital and, from 2022, also at the Department of Microbiology and Immunology, Chang Gung University. πŸ§ͺπŸ”¬πŸ“š

πŸ”¬ Research Focus

Prof. Chyi-Liang Chen specializes in infectious diseases, microbiology, and immunology. His research spans viral infections 🦠, antimicrobial resistance πŸ’Š, and host-pathogen interactions πŸ₯. He has contributed to studies on multiple viral infections in children, cytomegalovirus colitis, and antiviral treatments. His work also explores the gut microbiota’s role in cancer therapy and cross-species microRNAs. Additionally, he has investigated COVID-19 therapeutics 😷 and SARS-CoV-2 variants 🧬. His studies provide crucial insights into infectious disease management, making significant contributions to global health and microbiological research. πŸŒπŸ”

Publication Top Notes

1️⃣ Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan πŸ¦ πŸ’Š (Heliyon, 2025)Β 
2️⃣ Identifying the function of novel cross-species microRNAs from the excretory-secretory products of Angiostrongylus cantonensis fifth-stage larvae 🧬🦠 (Journal of Microbiology, Immunology and Infection, 2025)Β 
3️⃣ Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates 🀰🦠 (Pathogens, 2025)Β 
4️⃣ Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases πŸ’ŠπŸ¦  (BMC Infectious Diseases, 2024) – 2 citations
5️⃣ Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer 🦠πŸ§ͺ (Biomedical Journal, 2024) – 5 citations
6️⃣ Antimicrobial activity of eravacycline and other comparative agents on aerobic and anaerobic bacterial pathogens in Taiwan πŸ’ŠπŸ¦  (Journal of Global Antimicrobial Resistance, 2024) – 1 citation
7️⃣ Complete genome sequence of Bacillus halotolerans F29-3, a fengycin-producing strain 🧬🦠 (Microbiology Resource Announcements, 2024)Β 
8️⃣ Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review πŸ¦ πŸ“– (Viruses, 2024) – 5 citations
9️⃣ Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(Ξ±K) in mild-to-moderate COVID-19 patients πŸ’‰πŸ¦  (Human Vaccines and Immunotherapeutics, 2024)Β 
πŸ”Ÿ Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives πŸ¦ πŸ’‰ (Journal of the Formosan Medical Association, 2024) – 1 citation

Conclusion

Prof. Chyi-Liang Chen is highly suitable for the Best Researcher Award due to his strong academic background, international research experience, expertise in microbiology and bacterial pathogenesis, and high-impact publications. His work has significantly advanced molecular microbiology and biotechnology, making him a worthy candidate for this prestigious recognition.

HΓΌray Ilayda KΓΆk | Biomechanics | Best Researcher Award

Posted on by ScienceFather

Ms. HΓΌray Ilayda KΓΆk | Biomechanics | Best Researcher Award

PhD student at Leibniz University Hannover, Germany

HΓΌray Ilayda KΓΆk is a research associate at the Institute of Continuum Mechanics, Leibniz University Hannover. She holds a Master’s degree (2022) with a thesis on finite element modeling of low cycle fatigue in steel specimens. Her research focuses on the mechanical characterization and numerical modeling of additively manufactured implants, particularly magnesium-based bioresorbable structures. She actively contributes to DFG Research Group 5250 and co-organizes Meet the In(g)dustry to bridge academia and industry. Additionally, she serves as deputy head of VDI Hannover’s Development & Design working group. πŸŒβš™οΈπŸ”©

Publication Profile

Google Scholar

Academic and Professional Background

HΓΌray Ilayda KΓΆk, M.Sc., is a research associate at the Institute of Continuum Mechanics at Leibniz University Hannover since 2022. She earned her Master’s degree in 2022, specializing in finite element modeling of low cycle fatigue behavior of steel specimens under the guidance of Prof. Dr.-Ing. Ørjan Fyllingen and Prof. Dr.-Ing. Ragnar Gjengedal at Western Norway University of Applied Sciences. Her 2019 Bachelor’s thesis focused on designing and assembling a gearbox for an electrified high-speed drivetrain in collaboration with Leibniz University Hannover, Lenze SE Hameln, and Purdue University, USA. She also serves as deputy head of VDI Hannover’s Development & Design working group, focusing on methodological development, new tools, and product data management. βš™οΈπŸ“ŠπŸ”©

πŸ”¬ Research Focus

HΓΌray Ilayda KΓΆk’s research centers on biomechanical engineering and computational modeling, with a focus on additively manufactured implants 🦾. She specializes in finite element simulations πŸ–₯️ to predict the mechanical behavior of permanent and bioresorbable magnesium-based structures βš™οΈ, considering physiological loading and corrosion conditions. As part of DFG Research Group 5250, she contributes to lattice structure optimization for improved implant longevity and biocompatibility πŸ₯. Her interdisciplinary work bridges numerical modeling and experimental validation πŸ”„. Additionally, she fosters academia-industry collaboration through Meet the In(g)dustry, advancing biomedical innovations and engineering solutions for healthcare. πŸ—οΈπŸ”

Publication Top Notes

1️⃣ Reduction of stress-shielding and fatigue-resistant dental implant design through topology optimization and TPMS lattices – Journal of the Mechanical Behavior of Biomedical Materials, Cited by: -, πŸ“… 2025 πŸ¦·βš™οΈ

2️⃣ Topology optimization and high cycle fatigue modeling in additively manufactured dental implants – Transactions on Additive Manufacturing Meets Medicine 6 (S1), 1853-1853, Cited by: -, πŸ“… 2024 πŸ¦ΎπŸ”¬

3️⃣ S25: Computational and mathematical methods in data science – Minisymposia 16, 590, Cited by: -, πŸ“… 2023 πŸ“ŠπŸ“ˆ

4️⃣ S03: Damage and fracture mechanics – Minisymposia 16 202, 118, Cited by: -, πŸ“… 2018 πŸ”©πŸ”

5️⃣ Characterization and modeling of additively manufactured Ti-6Al-4V alloy with modified surfaces for medical applications – Frontiers in Bioengineering and Biotechnology 13, 1526873, Cited by: -, πŸ“… 2023 πŸ₯βš’οΈ

 

Anusha Thumma | Pharmaceutical Sciences| Best Researcher Award

Posted on by ScienceFather

Dr. Anusha Thumma | Pharmaceutical Sciences | Best Researcher Award

scientist at nova southeastern university, United States

Dr. Anusha Thumma holds a Ph.D. in Pharmaceutical Sciences and specializes in drug formulation, abuse-deterrent technologies, inhalation products, and vaccine adjuvants. With expertise in HPLC, qPCR, ELISA, DSC, and flow cytometry, she ensures regulatory compliance with FDA, ICH, GMP, and GLP standards. She has worked as an Associate Scientist at Lupin Pharmaceuticals, an R&D Scientist at US Pharma LTD, and an Associate Professor at Radex Regulatory Affairs. Her research includes mRNA vaccine lipid nanoparticles and opioid abuse-deterrent formulations. She excels in project management, data analysis (Minitab), and cross-functional collaboration.

Publication Profile

Orcid

πŸŽ“ Education

Dr. Anusha Thumma holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Nova Southeastern University, USA (2023), where her dissertation focused on Abuse-Deterrent Composites: A Multi-Angle Approach. She earned her Master of Pharmacy (MPharm) from Osmania University, India (2013), specializing in Formulation and Characterization of Imiquimod Multiple Emulsion as a Novel Vaccine Delivery System. Her academic journey began with a Bachelor of Pharmacy (BPharm) from Kakatiya University, India (2011). With a strong foundation in pharmaceutical sciences, her research contributions span drug formulation, regulatory affairs, and vaccine development. πŸ’ŠπŸ”¬

πŸ† Academic Excellence & Professional Achievements

Dr. Anusha Thumma has been recognized with multiple prestigious scholarships and grants for her outstanding academic and research contributions. She received a fully funded PhD scholarship and a PhD Scholar Stipend from Nova Southeastern University, USA, along with the President’s Faculty Research and Development Grant and HPD Research Grant for her research excellence. She also secured fully funded scholarships for her Master’s (Osmania University) and Bachelor’s (Kakatiya University) degrees in India. Additionally, she holds a Professional Diploma in Regulatory Affairs (USA), is a Registered Pharmacist (India), and has attended webinars on drug discovery. πŸ“œπŸŽ“πŸ’Š

 

πŸ”¬ Research Focus Areas

Dr. Anusha Thumma’s research primarily focuses on environmental remediation 🌱, pharmaceutical sciences πŸ’Š, and drug abuse potential πŸ§ͺ. She has made significant contributions to water purification by exploring biochar-based adsorption for removing heavy metals (cadmium, zinc, arsenic) and dyes from polluted water. Her expertise extends to pharmaceutical formulations, particularly in abuse-deterrent drug delivery systems. Additionally, she investigates the toxicity and abuse potential of fentanyl analogues. Her interdisciplinary work integrates biopolymer-based cryostructures, advancing biomedical and pharmaceutical applications. Through her research, she aims to enhance sustainable environmental solutions and safer pharmaceutical formulations. πŸŒπŸ”¬πŸ’§

Publication Top Notes

  • Adsorptive removal of arsenic from drinking water using KOH-modified sewage sludge-derived biochar

  • Exploring the efficiency of sodium alginate beads and Cedrus deodara sawdust for adsorptive removal of crystal violet dye

  • Advances in cryostructures and their applications in biomedical and pharmaceutical products

  • Abuse potential of fentanyl and fentanyl analogues

  • Removal of cadmium and zinc from water using sewage sludge-derived biochar

  • Potential of easily available low-cost raw cotton for the elimination of methylene blue dye from polluted water

Haojie Shan | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Haojie Shan | Medicine and Dentistry | Best Researcher Award

Dr. Haojie Shan, Department of orthopedic surgery, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Dr. Haojie Shan is a dedicated Resident Surgeon at the Department of Orthopaedic Surgery, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University. He holds a Ph.D. and M.D. in Orthopaedic Surgery from the same university and a B.S. in Clinical Medicine from Henan University. His research interests include osteonecrosis of the femoral head, bone immunity, and biomedical materials. Dr. Shan has authored numerous publications and holds several patents in surgical innovation. He has received prestigious awards, including a Gold Award in the International Innovation Competition for College Students in China. πŸ“šπŸ†πŸ¦΄

 

Publication Profile

Scopus

Education

Dr. Haojie Shan completed his academic journey in the field of orthopaedic surgery with impressive credentials. He earned his Ph.D. in Surgery (Orthopaedics) from Shanghai Jiao Tong University in June 2023, following the completion of his M.D. in the same specialty in June 2020. Prior to that, he obtained his B.S. in Clinical Medicine from Henan University in June 2017. Dr. Shan’s extensive education reflects his dedication to advancing medical knowledge and surgical techniques in orthopaedics. πŸ¦΄πŸŽ“πŸ₯

 

Research Interests

Dr. Haojie Shan is deeply engaged in innovative research within the field of orthopaedics, focusing on several critical areas. His primary interests include osteonecrosis of the femoral head, where he explores its underlying mechanisms and treatment strategies. He also investigates bone immunity and regeneration, aiming to enhance healing processes. Furthermore, Dr. Shan studies bone and soft tissue infections, seeking to improve diagnosis and therapeutic approaches. His work extends to the development and application of biomedical materials, which play a crucial role in orthopaedic surgery. His research contributes significantly to advancing patient care and treatment outcomes. πŸ¦΄πŸ”¬πŸ’‰βœ¨

 

Honors and Awards

Dr. Haojie Shan has garnered numerous accolades for his exceptional contributions to the field of orthopaedics and medical innovation. In 2024, he received the Gold Award in the Shanghai Division and a National Silver Award at the International Innovation Competition for College Students in China. His achievements include winning the First Prize at the 12th International Conference on Rehabilitation Medicine and Engineering Innovation Competition in 2023. Additionally, he secured the Second Prize for “Outstanding Youth” Papers at the same conference. Dr. Shan also earned a Third Prize in the China Medical Device Innovation and Entrepreneurship Competition and received recognition at various other esteemed events. πŸ₯‡πŸ†πŸŽ–οΈβœ¨

 

Conclusion

Dr. Haojie Shan’s combination of education, research expertise, innovative contributions, and recognition in the orthopaedic surgery domain make him a highly suitable candidate for the Research for Best Researcher Award. His work not only demonstrates academic excellence but also a profound commitment to advancing medical science for improved patient outcomes.

 

Publication Top Notes Β 

  • A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm – Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X. (2025) – 0 citations πŸ“œ
  • Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections – Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X. (2024) – 0 citations πŸ’‰
  • An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing – Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C., Yu, X. (2024) – 0 citations 🩹
  • Scd-1 deficiency promotes the differentiation of CD8+ T effector – Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X. (2024) – 1 citation πŸ’‰
  • Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways – Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X. (2023) – 4 citations βš–οΈ
  • Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1Ξ± – Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T., Yu, X. (2023) – 2 citations 🦡
  • The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis – Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y., Yu, X. (2023) – 0 citations 🦠
  • Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination – Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z., Yu, X. (2023) – 0 citations πŸ”¬
  • Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis – Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X. (2022) – 9 citations 🦠
  • Ginsenoside Rg1 enhances the healing of injured tendon in Achilles tendinitis through the activation of IGF1R signaling mediated by oestrogen receptor – Wu, T., Qi, W., Shan, H., … Lu, Y., Wang, F., Yu, X. (2022) – 6 citations 🌱

 

 

 

Nilank Shah MD | Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Nilank Shah MD | Medicine | Best Researcher Award

Course Director and Professor, Touro College of Osteopathic Medicine, United States

An accomplished medical professional with extensive expertise in pharmacology and toxicology, this individual has dedicated their career to advancing medical education and research. They have held various prestigious positions, including Principal Investigator at TouroCOM, where they focus on organ preservation and therapeutic solutions. Their commitment to innovation in teaching methodologies and multidisciplinary research reflects a deep passion for both education and health science. 🌟

Publication Profile

Google Scholar

Education

Graduating with an MBBS from MPS Medical College & Hospital in India, they further specialized with an MD in Pharmacology and Applied Therapeutics from the same institution. Their academic journey continued with an MS in Pharmacology & Toxicology from Long Island University, USA, followed by a Post-Doctoral Fellowship in Physiology and Pharmacology at the State University of New York. Additionally, they completed certificate programs in Food & Nutrition and Nutrition & Care with first-class honors from Indira Gandhi National University. πŸŽ“

Experience

With a robust background in both clinical practice and academia, this professional has successfully integrated teaching with research. They have developed special methodologies and new pedagogies that enhance the learning experience for students in health sciences. Their role as a Principal Investigator on multiple funded research projects at TouroCOM highlights their ability to lead impactful studies in the field. πŸ’Ό

Research Focus

Their research primarily concentrates on organ preservation solutions and the therapeutic effectiveness of innovative oxygen carriers in cardiac care. This work exemplifies their commitment to advancing healthcare through rigorous scientific investigation, bridging clinical applications with cutting-edge research in pharmacology and toxicology. πŸ”¬

Awards and Honors

This individual has received numerous accolades for their contributions to medical research and education, including several funded research grants as Principal Investigator. Their recognition underscores their role as a leader in the field and their dedication to improving health outcomes through science and education. πŸ†

Publication Top Notes

“Organ Preservation Solution: A Multidisciplinary Approach” – Journal of Clinical Pharmacology (2023) Cited by 30 articles

“Therapeutic Effectiveness of OxyVita Hemoglobin Based Oxygen Carrier” – Cardiology Research (2022) Cited by 25 articles

“Advancements in Organ Transplantation: A Review” – American Journal of Transplantation (2021) Cited by 40 articles

“Innovative Teaching Methodologies in Medical Education” – Medical Education Online (2020) Cited by 15 articles

 

Guanwei Fan | Cardiovascular research | Best Researcher Award

Posted on by ScienceFather

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. πŸ“šβ€οΈ

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes Β 

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-ΞΊB signaling pathway. Journal of Ethnopharmacology, 2024. πŸ“–
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. πŸ“–
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. πŸ“–
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. πŸ“–
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLRβˆ’/βˆ’ mice. Phytomedicine, 2024. πŸ“–
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. πŸ“–
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. πŸ“–
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. πŸ“–
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. πŸ“–
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. πŸ“–

 

 

 

Assunta Andreozzi | Bio Heat Transfer | Women Researcher Award

Posted on by ScienceFather

Prof. Assunta Andreozzi | Bio Heat Transfer | Women Researcher Award

Prof. Assunta Andreozzi, UniversitΓ  di Napoli Federico II, Italy

 

Prof. Assunta Andreozzi, born on May 12, 1972, in Aversa (CE), is a distinguished aerospace engineer. She graduated with honors in Aerospace Engineering from the University of Campania β€œLuigi Vanvitelli” in 1998 and obtained her PhD in Aerospace Sciences in 2001. With over 250 publications and an h-index of 21, her research spans heat transmission, solar energy systems, and thermo-fluid dynamics, significantly impacting engineering fields. Currently, she teaches at the University of Naples Federico II and supervises numerous theses, shaping the next generation of engineers. Prof. Andreozzi’s contributions have garnered recognition and respect in academia. πŸ“šπŸ”¬βœˆοΈ

 

Publication profile

Scopus

Orcid

Academic Career 🌟

Prof. Assunta Andreozzi began her academic journey by winning admission to the PhD course in Science and Aerospace Technologies at the Second University of Naples in 1999. In 2001, she collaborated with Prof. Yogesh Jaluria at Rutgers University on thermofluiddynamic analysis. She received a research grant at the Department of Aerospace Engineering, focusing on energy-efficient structural optimization methodologies. After earning her PhD in Aerospace Sciences in 2001, she became a university researcher at the University of Naples Federico II in 2002 and was confirmed in her role in 2005, contributing significantly to industrial technical physics. πŸŽ“βœˆοΈπŸ“š

 

University Teaching Activity πŸ“šπŸ‘©β€πŸ«

Prof. Assunta Andreozzi has significantly contributed to the education of Bachelor’s and Master’s students at the University of Naples Federico II, teaching various engineering disciplines, including Construction, Electrical, Mechanical, and Environmental Engineering. Currently, she is involved in the Mechanical Engineering degree program, focusing on Technical Physics, Heat Transmission, Environmental Control, and Computational Thermofluid Dynamics. Since 2000, she has been responsible for multiple university courses annually, overseeing examination commissions and supervising numerous theses on energy efficiency, heat transfer, and fire dynamics. Her dedication has enriched the academic experience for aspiring engineers. πŸ”§πŸŒβœ¨

 

Research Activities πŸ”¬πŸ“Š

Prof. Assunta Andreozzi’s research portfolio includes over 250 publications, with 123 indexed in the Scopus database, accumulating 1,345 citations and an h-index of 21 as of March 16, 2024. Her research spans numerical, analytical, and experimental investigations, focusing on key areas such as heat transmission applications, solar energy system design, thermo-fluid dynamics in aircraft, and fire dynamics characterization. Additional topics include bioheat transfer and sloshing effects. Funding for her research has come from the European Community, the Ministry of University and Scientific Research, and private industry partnerships, highlighting her impactful contributions to engineering science. πŸŒβš™οΈπŸ”

 

Publication Top Notes

  • Procedures for Experimental Characterization of Thermal Properties in Li-Ion Battery Modules and Parameters Identification for Thermal Models (Fiorillo et al.)Β  2024 πŸ“„
  • Numerical evaluation of heat-triggered drug release via thermo-sensitive liposomes: A comparison between image-based vascularized tumor and volume-averaged porous media models (Adabbo et al.) – 2 citations, 2024 πŸ’Š
  • A THERMAL ANALYSIS OF A FUNCTIONALLY-GRADED GYROID AS A HEAT SINK (Anacreonte et al.)Β  2024 πŸ”₯
  • LASER ABLATION FOR PROSTATE CANCER THERAPIES: MATHEMATICAL MODELING (Andreozzi et al.) 2024 πŸ”¬
  • Numerical analysis of the binder angle effect on convective heat transfer and pressure drop in drilled-hollow sphere architected foams (Iasiello et al.) – 0 citations, 2024 πŸ—οΈ
  • Microwave ablation modeling with AMICA antenna: Validation by means a numerical analysis (Cafarchio et al.) – 2 citations, 2023 πŸ“‘
  • Heat Transfer and Thermal Energy Storage Enhancement by Foams and Nanoparticles (Andreozzi et al.) – 3 citations, 2023 β˜€οΈ
  • A 3D numerical model of controlled drug delivery to solid tumor by means of mild microwave hyperthermia-activated thermo-sensitive liposomes (Adabbo et al.) – 8 citations, 2023 πŸ’‰
  • Emprint Microwave Thermoablation System: Bridging Thermal Ablation Efficacy between Human Patients and Porcine Models through Mathematical Correlation (Cafarchio et al.) – 3 citations, 2023 πŸ–
  • Numerical Investigation on Natural Convection in Inclined Channels Partially Filled With Asymmetrically Heated Metal Foam (Andreozzi et al.) – 4 citations, 2023 πŸ“

 

 

Sara Mahshid | Biomedical Engineering | Best Researcher Award

Posted on by ScienceFather

Prof. Sara Mahshid | Biomedical Engineering | Best Researcher Award

Prof. Sara Mahshid, McGill, Canada

Based on the information provided about Prof. Sara Mahshid, here’s an assessment of her suitability for the “Best Researcher Award” considering her credentials:

Publication profile

Education

Prof. Sara Mahshid holds a robust educational background with a PhD in Materials Science & Engineering (2006-2011) from Sharif University of Technology, Iran. She also earned her M.Sc. (2003-2005) and B.Sc. (1999-2003) in Materials Science & Engineering from the same institution. This solid academic foundation underpins her expertise in the field.

Academic Appointments

Prof. Mahshid is currently an Assistant Professor in the Department of Bioengineering at McGill University (since 2017). Her diverse experience includes roles as a Post-Doctoral Researcher at the University of Toronto and McGill University, and as a Lecturer at Monash University, Malaysia. These positions reflect a strong track record in both teaching and research across various institutions.

Professional Affiliations

Her affiliations with prestigious institutions, such as the Division of Experimental Medicine, McGill University, and several interdisciplinary initiatives, showcase her active involvement in advancing her field. Memberships in the Center of Antimicrobial Resistance (AMR) and the McGill Interdisciplinary Initiative in Infection and Immunity (Mi4) highlight her commitment to tackling critical issues in bioengineering and related areas.

Awards and Distinctions

Prof. Mahshid has received numerous accolades, including the Tech Accel IR Award (2024) and the MI4-PFizer Early Career Investigator Award (2023). Her recognition through the McGill Innovation Fund, William and Rhea Seath Awards, and the Principal’s Prize for Outstanding Emerging Researchers emphasizes her significant contributions and innovations in her research field.

Publication Top Notes

  • Synthesis of TiO2 nanoparticles by hydrolysis and peptization of titanium isopropoxide solution 🌟 – 604 citations, 2007
  • Electrochemical sensors and biosensors based on the use of polyaniline and its nanocomposites: A review on recent advances πŸ“Š – 202 citations, 2019
  • Are plasmonic optical biosensors ready for use in point-of-need applications? πŸ”¬ – 174 citations, 2020
  • A review on recent advancements in electrochemical biosensing using carbonaceous nanomaterials πŸ”‹ – 135 citations, 2019
  • Mixed-phase TiO2 nanoparticles preparation using sol–gel method πŸ§ͺ – 134 citations, 2009
  • The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2 🦠 – 132 citations, 2021
  • Sensitive determination of dopamine in the presence of uric acid and ascorbic acid using TiO2 nanotubes modified with Pd, Pt and Au nanoparticles 🧫 – 131 citations, 2011
  • Oxidation mechanism of C in MgO–C refractory bricks πŸ”₯ – 129 citations, 2006
  • Template-based electrodeposition of Pt/Ni nanowires and its catalytic activity towards glucose oxidation βš›οΈ – 123 citations, 2011
  • Effect of Al antioxidant on the rate of oxidation of carbon in MgO–C refractory πŸ§ͺ – 92 citations, 2007
  • Electrodeposition and electrocatalytic properties of Pt/Ni–Co nanowires for non-enzymatic glucose detection 🧫 – 74 citations, 2013
  • An AgNP-deposited commercial electrochemistry test strip as a platform for urea detection πŸ§ͺ – 60 citations, 2020
  • A hierarchical 3D nanostructured microfluidic device for sensitive detection of pathogenic bacteria 🦠 – 58 citations, 2018
  • Mechanistic control of the growth of three-dimensional gold sensors πŸ’Ž – 58 citations, 2016
  • Mixed confinement regimes during equilibrium confinement spectroscopy of DNA 🧬 – 57 citations, 2014
  • A Nanostructured Gold/Graphene Microfluidic Device for Direct and Plasmonic-Assisted Impedimetric Detection of Bacteria πŸ§ͺ – 56 citations, 2020
  • Experimental evidence of weak excluded volume effects for nanochannel confined DNA 🧬 – 56 citations, 2015
  • Convex lens-induced nanoscale templating πŸ”¬ – 54 citations, 2014
  • Nanopattern-Assisted Direct Growth of Peony-like 3D MoS2/Au Composite for Nonenzymatic Photoelectrochemical Sensing 🌺 – 50 citations, 2020
  • Plasmonic Nanobowtiefluidic Device for Sensitive Detection of Glioma Extracellular Vesicles by Raman Spectrometry 🧬 – 48 citations, 2021

Conclusion

Prof. Sara Mahshid’s distinguished educational background, impressive academic appointments, active professional affiliations, and substantial awards make her a strong candidate for the “Best Researcher Award.” Her ability to overcome challenges and maintain a high level of research excellence further solidifies her suitability for this recognition.

 

Peng Zhang | Biological Science | Best Researcher Award

Posted on by ScienceFather

Dr. Peng Zhang | Biological Science | Best Researcher Award

Assistant Professor, Tianjin University of Technology, China

Dr. Peng Zhang is an Assistant Professor at the Life and Health Intelligent Research Institute, Tianjin University of Technology. With a strong focus on understanding gut microbiota and its impact on health, Dr. Zhang combines expertise in natural product research with advanced omics technologies. His work explores innovative ways to improve bioavailability and efficacy of therapeutic agents. 🌟

Publication Profile

Strengths for the Award:

  1. Innovative Research Focus: Peng Zhang’s work on natural products, drug delivery systems, and the role of gut microbiota in health demonstrates a high level of innovation and relevance in the field of life and health sciences.
  2. Significant Publications: Zhang has a strong publication record in reputable journals, including Journal of Functional Foods, Journal of Agricultural and Food Chemistry, and The ISME Journal. His research on gut microbiota and its impact on health conditions showcases his expertise and contributions to the field.
  3. Active Projects: Leading national projects funded by the National Natural Science Foundation of China, Zhang’s research includes high-impact topics like antibiotic resistance and its effects on gut microbiota. This aligns with current global health challenges.
  4. Diverse Experience: Zhang’s experience spans from studying the effects of natural products on obesity to the development of nanotechnology-based drug delivery systems, indicating a broad and applied approach to research.

Areas for Improvement:

  1. Broader Impact and Outreach: While Zhang’s research is impactful, expanding efforts to disseminate findings to a wider audience, including the general public and policymakers, could enhance the societal impact of his work.
  2. Collaborations and Networking: Increasing collaborations with international researchers and institutions could further strengthen his research’s global relevance and visibility.
  3. Grant and Project Diversification: Although Zhang has led and participated in significant projects, diversifying funding sources and project scopes might provide additional opportunities for groundbreaking research.

Education

Dr. Zhang earned his PhD from Nankai University, Tianjin, China, in 2021, where he developed models to study the role of gut microbiota in health crises caused by antibiotics. Prior to this, he completed his graduate studies at Hainan University, Haikou, China, focusing on the effects of dietary compounds on obesity. πŸŽ“

Experience

2022 – Present: Assistant Professor, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin, China. Research includes purifying natural products and developing nanotechnology-based drug delivery systems. πŸ”¬2017 – 2021: PhD student, Nankai University, Tianjin, China. Developed models to study antibiotic exposure and drug-resistant bacteria. πŸ§ͺ2015 – 2017: Graduate student, Hainan University, Haikou, China. Examined effects of Luo Han Guo on obesity. 🌿

Research Focus

Dr. Zhang’s research primarily investigates the role of natural products in alleviating inflammatory diseases and improving gut health. His projects include:

Purifying Natural Products: Studying polysaccharides and polyphenols from medicinal foods to understand their impact on inflammatory diseases and gut microbiota. 🌱Drug Delivery Systems: Developing nanotechnology-based encapsulation systems to enhance the bioavailability of active compounds. πŸš€

Awards and Honours

Dr. Zhang’s contributions to the field are recognized through various awards and honors. Notable mentions include his significant contributions to understanding the interactions between gut microbiota and therapeutic agents. πŸ…

Publications Top Note

Biological Science, Biological Research, Life Sciences

  1. Polysaccharides isolated from Hibiscus sabdariffa L. mitigate intestinal radiation injury, Journal of Functional Foods, 2024.
  2. Polysaccharide Isolated from Agaricus blazei Murill Alleviates Intestinal Ischemia/Reperfusion Injury, Journal of Agricultural and Food Chemistry, 2024.
  3. The Gut Microbiota Contributes to Systemic Responses and Liver Injury in Gut-Derived Sepsis, Microorganisms, 2023.
  4. Porphyromonas gingivalis exacerbates alcoholic liver disease, Journal of Clinical Periodontology, 2023.
  5. Gut microbiota exaggerates triclosan-induced liver injury, Journal of Hazardous Materials, 2022.

 

Conclusion:

Peng Zhang is a highly qualified candidate for the Research for Best Researcher Award. His innovative research, strong publication record, and leadership in significant projects underscore his contributions to the field. Addressing areas for improvement, such as expanding outreach and fostering international collaborations, could further enhance his impact and recognition in the global research community.

 

Neda Mostajeran | Pharmaceutical Science Award | Best Researcher Award

Posted on by ScienceFather

Dr. Neda Mostajeran | Pharmaceutical Science Award | Best Researcher Award

Dr. Neda Mostajeran, Mashhad University of Medical Sciences, Iran

Dr. Neda Mostajeran is a Ph.D. candidate in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems including nanoliposomes, hydrogels, and nanofibers for applications in cancer therapy, wound healing, and ocular diseases. She has expertise in nanoformulations like liposomes and polymers, coupled with skills in tissue engineering and biochemical assays. With a background in Organic Chemistry and a strong publication record, she explores cutting-edge therapies such as non-coding RNA-based treatments. Driven by a passion for advancing healthcare through nanotechnology, she excels in scientific research, statistical analysis, and technical writing. 🧬

 

Publication profile

Professional Background

Dr. Neda Mostajeran is currently pursuing her Ph.D. in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research spans diverse areas including drug delivery systems, nano sensors, and hydrogel manufacturing, particularly focusing on nanoliposomes. She investigates factors influencing angiogenesis in cancer, wound healing, and ocular diseases, alongside exploring tissue engineering techniques for scaffold design like hydrogels and nanofibers. Her work extends to modern therapeutic nanosystems and the development of beads for localized osteomyelitis treatment. Proficient in MTT assay and HPLC, Dr. Mostajeran is dedicated to advancing nano-based drug delivery formulations such as liposomes, micelles, and polymers, with expertise in in-vitro biochemical and immunological assays. πŸ§ͺ

Educational Achievements

 

Dr. Mostajeran holds a Master’s degree in Organic Chemistry from Islamic Azad University and a Bachelor’s in Chemistry from Kashan University. She possesses additional skills in statistical analysis, technical writing, communication, teaching, RT-PCR, and cell culture. πŸ“š

 

Research Focus

Dr. Neda Mostajeran’s research primarily focuses on the design, solvent-free synthesis, and evaluation of antibacterial activity of coumarin sulfonamides. Her work, published in reputable journals like the Journal of the Iranian Chemical Society and Pharmaceutical Chemistry Journal, showcases her expertise in pharmaceutical chemistry and nanotechnology. Dr. Mostajeran collaborates extensively with peers on innovative approaches to synthesizing bioactive compounds and assessing their therapeutic potential, particularly in combating bacterial infections. Her contributions underscore a commitment to advancing drug discovery methodologies, integrating nanotechnology with organic chemistry to develop novel compounds that address significant health challenges. πŸ§ͺ

 

Publication Top Notes

Design, solvent-free synthesis and antibacterial activity evaluation of new coumarin sulfonamides

Design, Solvent-Free Synthesis and Antibacterial Activity Evaluation of New Coumarine Sulfonamides

Solvent-Free Synthesis and Antibacterial Evaluation of Novel Coumarin Sulfonamides